Reduced CD8+ T cells infiltration can be associated to a malignant transformation in potentially malignant oral epithelial lesions

[1]  T. Isomura,et al.  Intraepithelial CD8+ lymphocytes as a predictive diagnostic biomarker for the remission of oral lichen planus. , 2017, Human pathology.

[2]  A. Abushouk,et al.  Correlation between tissue expression of microRNA-137 and CD8 in oral lichen planus , 2018, Clinical Oral Investigations.

[3]  M. Young,et al.  Premalignant Oral Lesion Cells Elicit Increased Cytokine Production and Activation of T-cells. , 2016, Anticancer research.

[4]  K. Xia,et al.  An adaptive immune response driven by mature, antigen‐experienced T and B cells within the microenvironment of oral squamous cell carcinoma , 2016, International journal of cancer.

[5]  K. Wolff,et al.  CD274/PD-L1 gene amplification and PD-L1 protein expression are common events in squamous cell carcinoma of the oral cavity , 2016, Oncotarget.

[6]  B. Dunn,et al.  Immunologic approaches to cancer prevention-current status, challenges, and future perspectives. , 2016, Seminars in oncology.

[7]  B. Ryan,et al.  The hallmarks of premalignant conditions: a molecular basis for cancer prevention. , 2016, Seminars in oncology.

[8]  H. Vora,et al.  Infiltration of T cell subsets during oral carcinogenesis , 2016 .

[9]  A. Anderson,et al.  Marked variation in malignant transformation rates of oral leukoplakia , 2015, Evidence-Based Dentistry.

[10]  Mu-Kuan Chen,et al.  High PD-L1 Expression Correlates with Metastasis and Poor Prognosis in Oral Squamous Cell Carcinoma , 2015, PloS one.

[11]  Y. Ohmori,et al.  Tumor-associated macrophages in oral premalignant lesions coexpress CD163 and STAT1 in a Th1-dominated microenvironment , 2015, BMC Cancer.

[12]  R. Jacobs,et al.  Proinflammatory cytokine levels in oral lichen planus, oral leukoplakia, and oral submucous fibrosis , 2015, Journal of the Korean Association of Oral and Maxillofacial Surgeons.

[13]  M. Jontell,et al.  Presence of CD3-positive T-cells in oral premalignant leukoplakia indicates prevention of cancer transformation. , 2015, Anticancer research.

[14]  M. Young,et al.  An Inflammatory Cytokine Milieu is Prominent in Premalignant Oral Lesions, but Subsides when Lesions Progress to Squamous Cell Carcinoma , 2014, Journal of clinical & cellular immunology.

[15]  N. Rhodus,et al.  Oral cancer: leukoplakia, premalignancy, and squamous cell carcinoma. , 2014, Dental clinics of North America.

[16]  S. Jiang,et al.  Expression of E-cadherin, Twist, and p53 and their prognostic value in patients with oral squamous cell carcinoma , 2013, Journal of Cancer Research and Clinical Oncology.

[17]  W. William.  Oral premalignant lesions: any progress with systemic therapies? , 2012, Current opinion in oncology.

[18]  Y. Cho,et al.  Relationship between the expressions of PD-L1 and tumor-infiltrating lymphocytes in oral squamous cell carcinoma. , 2011, Oral oncology.

[19]  L. D. de Souza,et al.  Role of inflammation in oral carcinogenesis (Part I): Histological grading of malignancy using a binary system. , 2011, Oncology letters.

[20]  M. Prystowsky,et al.  Lymphocytic Host Response to Oral Squamous Cell Carcinoma: An Adaptive T-Cell Response at the Tumor Interface , 2011, Head and neck pathology.

[21]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[22]  T. Chen,et al.  Changes in peripheral blood lymphocyte phenotypes distribution in patients with oral cancer/oral leukoplakia in Taiwan. , 2010, International journal of oral and maxillofacial surgery.

[23]  P. Speight,et al.  Natural history of potentially malignant oral lesions and conditions: an overview of the literature. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[24]  S. Warnakulasuriya,et al.  Nomenclature and classification of potentially malignant disorders of the oral mucosa. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[25]  E. Tartour,et al.  Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers , 2006, Clinical Cancer Research.

[26]  T. Dietrich,et al.  Clinical risk factors of oral leukoplakia in a representative sample of the US population , 2004 .

[27]  I. Gannot,et al.  Increase in immune cell infiltration with progression of oral epithelium from hyperkeratosis to dysplasia and carcinoma , 2002, British Journal of Cancer.

[28]  W. Neville,et al.  Oral and Maxillofacial Pathology , 2004 .